EUCTR2008-005210-44-ESActive, not recruitingNot Applicable
Teofilina a dosis bajas como potenciador del tratamiento anti-inflamatorio en EPOC grave (Estudio ASSET) - ASSET
Organisation name was not entered0 sites0 target enrollmentStarted: December 22, 2008Last updated:
Conditions
Drugs
Trial Snapshot
- Phase
- Not Applicable
- Status
- Active, not recruiting
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional clinical trial of medicinal product
Eligibility Criteria
- Sex
- All
Inclusion Criteria
- •Los pacientes con diagnóstico de EPOC severo reclutados durante una hospitalización por una exacerbación de EPOC que cumplan los criterios de inclusión (Edad > 45 años, historia tabáquica de > 10 paquetes-año, diagnóstico de EPOC en estadíos III o IV de la GOLD (FEV1/FVC < 0.7 y post-BD FEV1 < 50% del valor de referencia))
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
Exclusion Criteria
- •Criterios de exclusión: Presencia de otra enfermedad inflamatoria crónica asociada o tumoral, diagnóstico confirmado de asma, pacientes con intolerancia conocida a teofilina.
Investigators
Similar Trials
Active, not recruiting
Not Applicable
Ajuste del tratamiento con tirofibán en pacientes que presentan resistencia a la aspirina o al clopidogrel: 3T/2RTailoring Treatment with Tirofiban in patients showing Resistance to aspirin and/or Resistance to clopidogrel: 3T/2R - 3T/2RPacientes con enfermedad coronaria que van a someterse a una intervención coronaria percutánea.Patients with coronary disease undergoing percutaneous coronary interventionMedDRA version: 9.1Level: LLTClassification code 10011099Term: Coronary diseaseEUCTR2007-002427-32-ESIVERSITA' DEGLI STUDI DI FERRARA250
Completed
Phase 4
The Role of Theophylline Plus Low-dose Formoterol-budesonide in Treatment of BronchiectasisBronchiectasisNCT01769898The First Affiliated Hospital of Guangzhou Medical University50
Active, not recruiting
Not Applicable
Tratamiento con inhibidores de tirosina quinasas en pacientes con variantes de mastocitosis sistémica de mal pronóstico: ensayo clínico para sujetos sin mutación D816V de KIT y búsqueda de inhibidores de KIT D816V+Mastocitosis sistémicaMedDRA version: 11Level: LLTClassification code 10042949Term: Mastocitosis sistémicaMedDRA version: 11Level: LLTClassification code 10056453Term: Mastocitosis sistémica agresivaEUCTR2010-019189-94-ESDr. Luis Escribano
Not yet recruiting
Not Applicable
study to improve treatment outcomes of Brain Fever(acute encephalitis syndrome) in childreCTRI/2022/08/044977All India Institute of Medical Sciences Bhubaneswar
Active, not recruiting
Not Applicable
Triiodothyronine as an adjunct to accelerate the antidepressant effects of the selective serotonin reuptake inhibitor (SSRI) escitalopramDepressive episodeMedDRA version: 9.1Level: LLTClassification code 10012402Term: Depressive episodeEUCTR2007-001540-45-LTInstitute of Psychophysiology and Rehabilitation (IRP) of the Kaunas University of Medicine60